We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.94B
AUM Growth
+$1.21B
Cap. Flow
+$1.03B
Cap. Flow %
14.89%
Top 10 Hldgs %
53.97%
Holding
274
New
81
Increased
95
Reduced
45
Closed
48

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$73.4M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$72M
3
JNJ icon
Johnson & Johnson
JNJ
+$64.2M
4
CL icon
Colgate-Palmolive
CL
+$62.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$52.1M

Top Sells

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$73.1M
2
FRPT icon
Freshpet
FRPT
+$58.3M
3
PARA
Paramount Global Class B
PARA
+$48M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$43.7M
5
KYNB
Kyntra Bio
KYNB
+$32.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.57%
2 Consumer Staples 5.26%
3 Consumer Discretionary 4.88%
4 Technology 4.62%
5 Communication Services 2.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMBLZ
226
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$535 ﹤0.01%
27,001
-2,672,999
-99% -$61.2K
ABEO icon
227
Abeona Therapeutics
ABEO
$413M
– –
-1,106,000
Closed -$3.41M
AKTX
228
Akari Therapeutics
AKTX
$12.3M
– –
-4,338
Closed -$1.63M
ATEC icon
229
Alphatec Holdings
ATEC
$1.44B
– –
-1,096,000
Closed -$13.5M
BDRX
230
Biodexa Pharmaceuticals
BDRX
$1.58M
– –
-1
Closed -$381K
BOXL icon
231
Boxlight
BOXL
$2.13M
– –
-1,812
Closed -$811K
BUD icon
232
AB InBev
BUD
$165B
– –
-498,000
Closed -$29.9M
CKPT
233
DELISTED
Checkpoint Therapeutics
CKPT
– –
-691,895
Closed -$3.54M
CLX icon
234
Clorox
CLX
$12.7B
– –
-173,000
Closed -$24.3M
COCO icon
235
Vita Coco
COCO
$3.6B
– –
-414,000
Closed -$5.72M
CROX icon
236
Crocs
CROX
$6.55B
– –
-50,000
Closed -$5.42M
ZSTK
237
ZeroStack Corp
ZSTK
$19M
– –
-5,344
Closed -$949K
FND icon
238
Floor & Decor
FND
$6.68B
– –
-68,000
Closed -$4.73M
RKTO
239
Rocket One Inc
RKTO
$18.9M
– –
-140,000
Closed -$1.09M
IDAI icon
240
T Stamp
IDAI
$18.1M
– –
-13,000
Closed -$469K
INM icon
241
InMed Pharmaceuticals
INM
$7.85M
– –
-4,858
Closed -$196K
KPTI icon
242
Karyopharm Therapeutics
KPTI
$48M
– –
-256,904
Closed -$13.1M
LUCYW icon
243
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$123K
– –
-210,000
Closed -$30.9K
OLLI icon
244
Ollie's Bargain Outlet
OLLI
$4.94B
– –
-108,000
Closed -$5.06M
OPTN
245
DELISTED
OptiNose
OPTN
– –
-133,099
Closed -$3.69M
PBYI icon
246
Puma Biotechnology
PBYI
$454M
– –
-300,000
Closed -$1.27M
PCRX icon
247
Pacira BioSciences
PCRX
$997M
– –
-1,892,000
Closed -$73.1M
PTN
248
Palatin Technologies
PTN
$13.8M
– –
-16,930
Closed -$2.17M
SCPH
249
DELISTED
scPharmaceuticals
SCPH
– –
-2,148,000
Closed -$15.4M
SHOP icon
250
Shopify
SHOP
$195B
– –
-256,000
Closed -$8.89M
7 8 9
10
11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Armistice Capital held 274 positions worth $6.94B, up 21% from $5.73B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital deployed $1.03B of net new capital in Q1 2023, opening 81 new positions and adding to 95 existing holdings. Its largest new stake was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Freshpet, an estimated $58.3M trimmed.

  • Armistice Capital's largest Q1 2023 buy was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.
  • Armistice Capital added most to UnitedHealth in Q1 2023, an estimated $73.4M increase.
  • Armistice Capital's biggest Q1 2023 reduction was Freshpet, cutting an estimated $58.3M.
  • Armistice Capital fully exited Pacira BioSciences in Q1 2023, selling an estimated $73.1M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.94B portfolio in Q1 2023.
  • Armistice Capital opened 81 new positions and closed 48 in Q1 2023.
  • Armistice Capital's portfolio value rose 21% quarter-over-quarter to $6.94B.

Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.